Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.51 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, triacetinum, e 171, e 172 (rubrum), pro compresso obducto corresp. lactosum monohydricum 82.32 mg. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 15 mg per ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 45 mg per ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 30 mg a ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum 32 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.087 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.12 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum 96 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.262 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 3.36 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, lactosum monohydricum 160 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.437 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.6 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, lactosum monohydricum 224 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.611 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 7.84 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.09 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 33.12 mg. - carcinoma a cellule renali - synthetika

Sveitsi - italia - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.27 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 99.36 mg. - carcinoma a cellule renali - synthetika